{"id":"NCT02466425","sponsor":"Shire","briefTitle":"Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)","officialTitle":"A Phase 3, Randomized, Double-blind, Multi-center, Placebo Controlled, Dose-Optimization, Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06-18","primaryCompletion":"2016-02-16","completion":"2016-02-16","firstPosted":"2015-06-09","resultsPosted":"2017-03-20","lastUpdate":"2021-06-03"},"enrollment":264,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Attention Deficit Hyperactivity Disorder (ADHD)"],"interventions":[{"type":"DRUG","name":"SHP465","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"SHP465","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The study is designed to evaluate the efficacy and safety of SHP465 in the treatment of ADHD in children and adolescents (aged 6-17 years). The primary objective of this study is to evaluate the efficacy of SHP465 administered as a daily morning dose compared to placebo in the treatment of children and adolescents (6-17 years of age inclusive) diagnosed with ADHD.","primaryOutcome":{"measure":"Change From Baseline in Attention-Deficit Hyperactivity Disorder Rating Scale-IV (ADHD-RS-IV) Total Score at Visit 6 (Week 4)","timeFrame":"Baseline, Visit 6 (Week 4)","effectByArm":[{"arm":"Placebo","deltaMin":40,"sd":6.96},{"arm":"SHP465","deltaMin":39,"sd":6.95}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":36,"countries":["United States"]},"refs":{"pmids":["28816509"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":131},"commonTop":["Decreased appetite","Headache","Insomnia","Nausea","Irritability"]}}